Related references
Note: Only part of the references are listed.Division and apoptosis of E2f-deficient retinal progenitors
Danian Chen et al.
NATURE (2009)
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells
Jean-Leon Chong et al.
NATURE (2009)
E2F2 represses cell cycle regulators to maintain quiescence
Arantza Infante et al.
CELL CYCLE (2008)
E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8
Erick J. Morris et al.
NATURE (2008)
Transgenic expression of E2F3a causes DNA damage leading to ATM-dependent apoptosis
Q. X. Paulson et al.
ONCOGENE (2008)
Deregulated E2f-2 underlies cell cycle and maturation defects in retinoblastoma null erythroblasts
Alexandra Dirlam et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop
Cynthia Timmers et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova et al.
NATURE (2006)
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Raffaella Di Micco et al.
NATURE (2006)
Deregulated replication licensing causes DNA fragmentation consistent with head-to-tail fork collision
Iain F. Davidson et al.
MOLECULAR CELL (2006)
E2f4 regulates fetal erythropoiesis through the promotion of cellular proliferation
Kathryn M. Kinross et al.
BLOOD (2006)
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
ZB Chen et al.
NATURE (2005)
The E2F transcriptional network: old acquaintances with new faces
DK Dimova et al.
ONCOGENE (2005)
Cyclin E in normal and neoplastic cell cycles
HC Hwang et al.
ONCOGENE (2005)
Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland
EL Denchi et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors
J Campisi
CELL (2005)
Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice
A Iglesias et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
High incidence of thymic epithelial tumors in E2F2 transgenic mice
B Scheijen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Deregulation of cyclin E in human cells interferes with prereplication complex assembly
S Ekholm-Reed et al.
JOURNAL OF CELL BIOLOGY (2004)
Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics
A Aslanian et al.
GENES & DEVELOPMENT (2004)
Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21CIP1, but not p16INK4a
U Herbig et al.
MOLECULAR CELL (2004)
Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway
AP Young et al.
ONCOGENE (2003)
Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice
FX Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion
CL Olsen et al.
ONCOGENE (2002)
E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis
JW Zhu et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity
M Murga et al.
IMMUNITY (2001)
The E2F1-3 transcription factors are essential for cellular proliferation
LZ Wu et al.
NATURE (2001)
The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development
D Balomenos et al.
NATURE MEDICINE (2000)
Share Paper
